Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Longleaf Partners Small-Cap Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"Longleaf Small-Cap trails markets amid late-cycle excess but maintains defensive positioning with 13.2% cash and high-60s P/V ratio. Portfolio focused on undervalued companies with shareholder-friendly management teams actively repurchasing shares."
Longleaf Partners Small-Cap Fund returned 2.03% in Q3 2025, trailing broader markets during what the manager characterizes as late-cycle market excess. The fund maintains a defensive posture with 13.2% cash and portfolio P/V ratio in the high-60s, providing significant margin of safety. Core holdings include CNX Resources, Becle, White Mountains, and Gruma, all trading at attractive valuations with management teams actively repurchasing shares. The manager identifies classic late-cycle warning signs including massive outperformance of unprofitable stocks and speculative IPO activity. Key risks include tariff uncertainty and economic headwinds affecting various sectors. However, the manager remains optimistic about long-term prospects, citing improved portfolio quality and multiple catalysts for value realization. Notable portfolio activity included new positions in Rayonier and an undisclosed holding, while exiting Hyatt, Oscar Health, Park Hotels, and Westrock Coffee. The strategy emphasizes patient capital deployment in high-quality businesses with strong free cash flow generation and shareholder-friendly management teams.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High conviction evident in concentrated portfolio approach, specific price targets for holdings like CNX Resources over $50, and willingness to maintain defensive positioning despite relative underperformance. Clear investment thesis articulated for each major holding.
Growth Outlook
Manager expresses concern about market excess and late-cycle conditions, noting massive outperformance of unprofitable stocks and speculative IPO activity. However, maintains long-term optimism about double-digit returns and portfolio prospects.
Risk Appetite
Portfolio positioned defensively with 13.2% cash and focus on margin of safety. Manager prefers to trail market rather than chase overvalued assets, indicating risk-averse positioning during current environment.
Capital Deployment
Moderate de-risking with 13.2% cash position and selective deployment. Added two new positions but exited four holdings, indicating cautious capital allocation during market excess period.
Forward Guidance
Manager expresses optimism about future return potential given portfolio P/V ratio in high-60s and improved quality. Expects management partners to continue offensive actions and multiple ways to win for holdings.
Language Signal
Language balances caution about market conditions with optimism about portfolio prospects. Uses terms like 'encouraged for future return potential' and 'multiple ways to win' while acknowledging current challenges.
Perceived Risk
High perceived risk evident from discussion of late-cycle market conditions, unprofitable stock outperformance, speculative IPO activity, and comparison to 1999-2000 market excess. Manager explicitly flags multiple risk factors.
Opportunity Density
Moderate opportunity density with manager finding selective opportunities in undervalued companies with strong management teams. Growing on-deck list mentioned, but overall environment characterized by market excess limiting attractive opportunities.
Time Horizon
Long-term patient capital approach evident from multi-year holding periods, focus on compounding value per share, and willingness to accept short-term underperformance for long-term double-digit returns.
